Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08KIB
|
|||
Former ID |
DIB012830
|
|||
Drug Name |
SAR-114137
|
|||
Indication | Pain [ICD-11: MG30-MG3Z] | Phase 1 | [1] | |
Company |
Sanofi
|
|||
Structure |
Download2D MOL |
|||
Formula |
C25H34N4O7S
|
|||
Canonical SMILES |
CCC(C(=O)C1=NOC(=N1)C2=CC=CC=C2)NC(=O)C(CC(=O)N3CCOCC3)CS(=O)(=O)CC(C)C
|
|||
InChI |
1S/C25H34N4O7S/c1-4-20(22(31)23-27-25(36-28-23)18-8-6-5-7-9-18)26-24(32)19(16-37(33,34)15-17(2)3)14-21(30)29-10-12-35-13-11-29/h5-9,17,19-20H,4,10-16H2,1-3H3,(H,26,32)/t19?,20-/m0/s1
|
|||
InChIKey |
IUMMRYVGHFJSRD-ANYOKISRSA-N
|
|||
CAS Number |
CAS 537706-31-3
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | From laboratory to pilot plant: the solid-state process development of a highly potent cathepsin S/K inhibitor. Eur J Pharm Biopharm. 2013 Apr;83(3):436-48. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.